Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025

Company Overview - Akebia Therapeutics, Inc. is a biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, founded in 2007 and headquartered in Cambridge, Massachusetts [3]. Upcoming Event - Akebia will present data at the National Kidney Foundation Spring Clinical Meetings 2025 (NKF SCM25) in Boston, MA from April 10-13, 2025 [1]. - The company will have posters displayed during the Exhibit Hall hours at NKF SCM25 [1]. Research Presentation - On April 10, 2025, Dr. Wolfgang Winkelmayer will present a poster titled "Vadadustat for Treatment of Anemia in Older vs Younger Patients With Dialysis-Dependent-CKD" during the Oral Poster Presentation: Research 3 session [2]. - Akebia will also have a booth (1121) at the NKF SCM25 for attendees to visit [2].